The weekly litigation news digest is live. Subscribe now

IP Verse

A Method For Treating Melanoma Using A Herpes Simplex Virus And An Immune Checkpoint Inhibitor

Patent No. EP3381942 (titled "A Method For Treating Melanoma Using A Herpes Simplex Virus And An Immune Checkpoint Inhibitor") was filed by Amgen on Aug 30, 2013. The application was issued on Oct 1, 2025.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
HOFFMANN EITLEJan 13, 2022-

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3381942

AMGEN
Application Number
EP18157842A
Filing Date
Aug 30, 2013
Status
Patent Maintained As Amended
Aug 29, 2025
Publication Date
Oct 1, 2025
External Links
Slate, EP3381942B2, Google Patents